MediPharm Labs Corp. (FRA:MLZ)

MediPharm Labs Statistics

Total Valuation

MediPharm Labs has a market cap or net worth of EUR 16.88 million. The enterprise value is 10.18 million.

Market Cap	16.88M
Enterprise Value	10.18M

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	420.76M
Shares Outstanding	n/a
Shares Change (YoY)	+4.10%
Shares Change (QoQ)	+1.30%
Owned by Insiders (%)	8.72%
Owned by Institutions (%)	0.00%
Float	384.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.60
PB Ratio	0.73
P/TBV Ratio	0.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.07
EV / Sales	0.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.33

Financial Position

The company has a current ratio of 3.20, with a Debt / Equity ratio of 0.01.

Current Ratio	3.20
Quick Ratio	2.18
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.06
Interest Coverage	-101.18

Financial Efficiency

Return on equity (ROE) is -19.36% and return on invested capital (ROIC) is -9.79%.

Return on Equity (ROE)	-19.36%
Return on Assets (ROA)	-8.03%
Return on Invested Capital (ROIC)	-9.79%
Return on Capital Employed (ROCE)	-17.37%
Revenue Per Employee	175,222
Profits Per Employee	-30,500
Employee Count	161
Asset Turnover	0.90
Inventory Turnover	3.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.62% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-17.62%
50-Day Moving Average	0.04
200-Day Moving Average	0.04
Relative Strength Index (RSI)	48.12
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MediPharm Labs had revenue of EUR 28.21 million and -4.91 million in losses. Loss per share was -0.01.

Revenue	28.21M
Gross Profit	8.54M
Operating Income	-4.02M
Pretax Income	-4.91M
Net Income	-4.91M
EBITDA	-2.96M
EBIT	-4.02M
Loss Per Share	-0.01

Balance Sheet

The company has 6.90 million in cash and 258,831 in debt, giving a net cash position of 6.64 million.

Cash & Cash Equivalents	6.90M
Total Debt	258,831
Net Cash	6.64M
Net Cash Per Share	n/a
Equity (Book Value)	23.17M
Book Value Per Share	0.06
Working Capital	11.74M

Cash Flow

In the last 12 months, operating cash flow was -4.29 million and capital expenditures -88,113, giving a free cash flow of -4.38 million.

Operating Cash Flow	-4.29M
Capital Expenditures	-88,113
Free Cash Flow	-4.38M
FCF Per Share	n/a

Margins

Gross margin is 30.28%, with operating and profit margins of -14.27% and -17.41%.

Gross Margin	30.28%
Operating Margin	-14.27%
Pretax Margin	-17.41%
Profit Margin	-17.41%
EBITDA Margin	-10.50%
EBIT Margin	-14.27%
FCF Margin	n/a

Dividends & Yields

MediPharm Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.10%
Shareholder Yield	-4.10%
Earnings Yield	-29.09%
FCF Yield	-25.91%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MediPharm Labs has an Altman Z-Score of -2.52 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.52
Piotroski F-Score	2